Jiangsu gdk Biotechnology Co., Ltd. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was CNY 12.47 million compared to CNY 30.04 million a year ago. Revenue was CNY 12.47 million compared to CNY 30.04 million a year ago. Net loss was CNY 2.64 million compared to CNY 5.29 million a year ago. Basic loss per share from continuing operations was CNY 0.03 compared to CNY 0.09 a year ago. Diluted loss per share from continuing operations was CNY 0.03 compared to CNY 0.09 a year ago.